Skip Navigation LinksHome > April 2014 - Volume 259 - Issue 4 > Intestinal Alkaline Phosphatase Prevents Antibiotic-Induced...
Annals of Surgery:
doi: 10.1097/SLA.0b013e31828fae14
Original Articles

Intestinal Alkaline Phosphatase Prevents Antibiotic-Induced Susceptibility to Enteric Pathogens

Alam, Sayeda Nasrin MD*; Yammine, Halim MD*; Moaven, Omeed MD*; Ahmed, Rizwan MD*; Moss, Angela K. MD*; Biswas, Brishti BS*; Muhammad, Nur MD*; Biswas, Rakesh BS*; Raychowdhury, Atri*; Kaliannan, Kanakaraju MD*; Ghosh, Sathi MD*; Ray, Madhury MD*; Hamarneh, Sulaiman R. MD*; Barua, Soumik*; Malo, Nondita S.*; Bhan, Atul K. MD; Malo, Madhu S. MD, PhD*; Hodin, Richard A. MD*

Supplemental Author Material
Collapse Box

Abstract

Objective: To determine the efficacy of oral supplementation of the gut enzyme intestinal alkaline phosphatase (IAP) in preventing antibiotic-associated infections from Salmonella enterica serovar Typhimurium (S. Typhimurium) and Clostridium difficile.

Background: The intestinal microbiota plays a pivotal role in human health and well-being. Antibiotics inherently cause dysbiosis, an imbalance in the number and composition of intestinal commensal bacteria, which leads to susceptibility to opportunistic bacterial infections. Previously, we have shown that IAP preserves the normal homeostasis of intestinal microbiota and that oral supplementation with calf IAP (cIAP) rapidly restores the normal gut flora. We hypothesized that oral IAP supplementation would protect against antibiotic-associated bacterial infections.

Methods: C57BL/6 mice were treated with antibiotic(s) ± cIAP in the drinking water, followed by oral gavage of S. Typhimurium or C. difficile. Mice were observed for clinical conditions and mortality. After a defined period of time, mice were killed and investigated for hematological, inflammatory, and histological changes.

Results: We observed that oral supplementation with cIAP during antibiotic treatment protects mice from infections with S. Typhimurium as well as with C. difficile. Animals given IAP maintained their weight, had reduced clinical severity and gut inflammation, and showed improved survival.

Conclusions: Oral IAP supplementation protected mice from antibiotic-associated bacterial infections. We postulate that oral IAP supplementation could represent a novel therapy to protect against antibiotic-associated diarrhea (AAD), C. difficile-associated disease (CDAD), and other enteric infections in humans.

© 2014 by Lippincott Williams & Wilkins.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.